New Key Statistics Module, Z-Score and F-Score
NYSE:RDY Key Ratios
| Market Cap $ M | 11,892.86 |
| Enterprise Value $ M | 11,264.88 |
| P/E(ttm) | 19.42 |
| PE Ratio without NRI | 20.37 |
| Forward PE Ratio | 19.92 |
| Price/Book | 3.78 |
| Price/Sales | 3.74 |
| Price/Free Cash Flow | 35.32 |
| Price/Owner Earnings | 17.17 |
| Payout Ratio % | 0.13 |
| Revenue (TTM) $ M | 3,279.00 |
| EPS (TTM) $ | 3.79 |
| Beneish M-Score | -2.34 |
| 10-y EBITDA Growth Rate % | 5.90 |
| 5-y EBITDA Growth Rate % | 18.90 |
| y-y EBITDA Growth Rate % | 21.70 |
| EV-to-EBIT | 13.27 |
| EV-to-EBITDA | 11.03 |
| PEG | 1.08 |
| Shares Outstanding M | 166.52 |
| Net Margin (%) | 19.24 |
| Operating Margin % | 23.99 |
| Pre-tax Margin (%) | 25.47 |
| Quick Ratio | 1.90 |
| Current Ratio | 2.55 |
| ROA % (ttm) | 15.48 |
| ROE % (ttm) | 21.44 |
| ROIC % (ttm) | 21.95 |
| Dividend Yield % | 0.68 |
| Altman Z-Score | 8.56 |
| Piotroski F-Score | 7.00 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA y-y | Y |
| Cash flow > Earnings | Y |
| Lower Leverage y-y | N |
| Higher Current Ratio y-y | Y |
| Less Shares Outstanding y-y | N |
| Gross Margin Increase y-y | Y |
| Higher Asset Turnover y-y | Y |
RDY Number of Guru Trades
RDY Volume of Guru Trades
Gurus Latest Trades with NYSE:RDY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:RDY is held by these investors
Total 1
Dr Reddy's Laboratories Ltd Insider Transactions
No Available Data
News about NYSE:RDY
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers